SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-21-124612
Filing Date
2021-10-08
Accepted
2021-10-08 16:14:37
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-1 tm2129373-1_s1.htm S-1 859427
2 EXHIBIT 5.1 tm2129373d2_ex5-1.htm EX-5.1 29586
3 EXHIBIT 10.43 tm2129373d2_ex10-43.htm EX-10.43 82377
4 EXHIBIT 23.1 tm2129373d2_ex23-1.htm EX-23.1 2066
5 GRAPHIC lg_nabriva-4c.jpg GRAPHIC 78973
6 GRAPHIC tm2129373d2_ex5-1img001.jpg GRAPHIC 2899
  Complete submission text file 0001104659-21-124612.txt   1087368
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-260146 | Film No.: 211315456
SIC: 2834 Pharmaceutical Preparations